Melanocortin receptors: Perspectives for novel drugs

European Journal of Pharmacology

Volumn 375, Issue 1-3, 1999, Pages 295-310

  Wikberg, Jarl E S ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b Melacure Therapeutics   (Sweden)

Author keywords

Function; Localization; Melanocortin receptor; Selective drug; Structure

Indexed keywords

ANTIOBESITY AGENT; CORTICOTROPIN DERIVATIVE; INTERMEDIN DERIVATIVE; MELANOCORTIN RECEPTOR; NEUROPEPTIDE; RECEPTOR SUBTYPE; SYNTHETIC PEPTIDE;

CLONING; DRUG DEVELOPMENT; GENE EXPRESSION; HUMAN; INFLAMMATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW;

EID: 0033011926     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00298-8     Document Type: Review

References (118)

1. Abou-Mohamed G., Papapetropolous A., Ulrich D., Catrava J.D., Tuttle R.R., Caldwell R.W. HP-228, a novel synthetic peptide inhibits the induction of nitric oxide synthase in vivo but not in vitro. J. Pharmacol. Exp. Ther. 275:1995;584-591.
2. Adan R.A.H., Oosterom J., Ludvigsdottir G., Brakkee J.H., Burbach J.P.H., Gispen W.H. Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors. Eur. J. Pharmacol. 269:1994;331-337.
3. Al-Obeidi F., Hadley M.E., Pettitt B.M., Hruby V.J. Design of a new class of superpotent cyclic α-melanotropins based on quenched dynamic simulations. J. Am. Chem. Soc. 111:1989;3413-3416.
4. Alvaro J.D., Tatro J.B., Quillan J.M., Fogliano M., Eisenhard M., Lerner M.R., Nestler E.J., Duman R.S. Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction. Mol. Pharm. 50:1996;583-591.
5. Alvaro J.D., Tatro J.B., Duman R.S. Melanocortins and opiate addiction. Life Sci. 61:1997;1-9.
6. Barret P., MacDonald A., Helliwell R., Davidson G., Morgan P. Cloning and expression of a new member of the melanocyte-stimulating hormone receptor family. J. Mol. Endocrinol. 12:1994;203-213.
7. Blanchard S.G., Harris C.O., Ittoop O.R., Nichols J.S., Parks D.J., Truesdale A.T., Wilkison W.O. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line. Biochemistry. 34:1995;10406-10411.
8. Boston B.A., Cone R.D. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology. 137:1996;2043-2050.
9. Bousquet-Melou A., Galitzky J., Lafontan M., Berlan M. Control of lipolysis in intra-abdominal fat cells of nonhuman primates: comparison with humans. J. Lipid Res. 36:1995;451-461.
10. Buggy J.J. Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/STAT pathway. Biochem. J. 331:1998;211-216.
11. Catania A., Rajora A., Capsoni F., Minonzio F., Star R.A., Lipton J.M. The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides. 17:1996;675-679.
12. Ceriani G., Diaz J., Murphree S., Catania A., Lipton J.M. The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation. 1:1994;28-32.
13. Chagnon Y.C., Chen W.J., Perusse L., Hagnon M., Nadeau A., Wilkinson W., Bouchard C. Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the Quebec family study. Mol. Med. 3:1997;663-673.
14. Chen W., Kelly M.A., Opitz-Araya X., Thomas R.E., Low M.J., Cone R.D. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell. 91:1997;789-798.
15. Chiao H., Kohda Y., McLeroy P., Craig L., Housini I., Star R.A. α-Melanocyte stimulating hormone protects against renal injury after ischemia in mice and rats. Clin. Invest. 99:1997;1165-1172.
16. Chhajlani V. Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem. Mol. Biol. Int. 38:1996;73-80.
17. Chhajlani V., Wikberg J.E.S. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309:1992;417-420.
18. Chhajlani V., Muceniece R., Wikberg J.E.S. Molecular cloning of a novel human melanocortin receptor. Biochem. Biophys. Res. Commun. 195:1993;866-873.
19. De Wied D., Wolterink G. Structure-activity studies on the neuroactive and neurotropic effects of neuropeptides related to ACTH. Ann. N.Y. Acad. Sci. 525:1988;130-140.
20. Eberle, A.N., 1988. The Melanotropins. Karger, Basel.
21. Erickson J.C., Hollopeter G., Palmiter R.D. Role of neuropeptide Y in the obesity and endocrine abnormalities of ob/ob mice. Science. 274:1996;1704-1707.
22. Ermak G., Slominski A. Production of POMC, CRH-R1, MC1, and MC2 receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL/6 mouse skin. J. Invest. Dermatol. 108:1997;160-165.
23. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168.
24. Fong T.M., Mao C., MacNeil T., Kalyani R., Smith T., Weinberg D., Tota M.R., Van der Ploeg L.H. ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochem. Biophys. Res. Commun. 237:1997;629-631.
25. Fathi Z., Iben L.G., Parker E.M. Cloning, expression and tissue distribution of a fifth melanocortin receptor subtype. Neurochem. Res. 20:1995;107-113.
26. Follenfant R.L., Nakamura-Craig M., Henderson B., Higgs G.A. Inhibition by neuropeptides of interleukin-1 beta-induced, prostaglandin-independent hyperalgesia. Br. J. Pharmacol. 98:1989;41-43.
27. 7]-α-MSH at the melanocortin receptor. Biochem. Biophys. Res. Commun. 202:1994;1266-1271.
28. 272 in human melanocortin 5 receptor determines its low affinity to MSH. Biochem. Biophys. Res. Commun. 236:1997;489-492.
29. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., Watson S.J., DelValle J., Yamada T. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268:1993;8246-8250.
30. Gantz I., Shimoto Y., Konda Y., Miwa H., Dickinson C.J., Yamada T. Molecular cloning, expression and characterization of a fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 200:1994;1214-1220.
31. Gilchrist P.N., Ben-Tovim D.I. Eating disorders revisited: I. Anorexia nervosa. Med. J. Aust. 169:1998;438-441.
32. Grunfeld C., Hagman J., Sabin E.A., Buckley D.I., Jones D.S., Ramachandran J. Characterization of adrenocorticotropin receptors that appear when 3T3-L1 cells differentiate into adipocytes. Endocrinology. 116:1985;113-117.
33. Hadley M.E., Marwan M.M., Al-Obeidi F., Hruby V.J., Castrucci A.M. Linear and cyclic alpha-melanotropin [4-10]-fragment analogues that exhibit superpotency and residual activity. Pigment Cell Res. 2:1989;478-484.
34. Hartmeyer M., Scholzen T., Becher E., Bhardwaj R.S., Schwartz T., Luger T.A. Human dermal micorvascular endothelial cells express the melanocortin receptor type 1 and produce levels of IL-8 upon stimulation with alpha-melanocyte stimulating hormone. J. Immunol. 159:1997;1930-1937.
35. Haskell-Luevano C., Sawyer T.K., Trumpp-Kallmeyer S., Bikker J.A., Humblett C., Gantz I., Hruby V. Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists. Drug Design Discovery. 14:1996;197-211.
36. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 38:1995;3454-3461.
37. Huh S.K., Lipton J.M. The protective effects of alpha-melanocyte stimulating hormone on canine brain stem ischemia. Neurosurgery. 40:1997;132-139.
38. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkmeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn O., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
39. Kapas S., Hagi-Pavli E., Brown D.W., Chhajlani V., Farthing P.M. Direct effects of corticotrophin on oral keratinocyte cell proliferation. Eur. J. Biochem. 256:1998;75-79.
40. Kask A., Rägo L., Mutulis F., Pahkla R., Wikberg J.E.S., Schiöth H.B. Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake infree-feeding rats. Biochem. Biophys. Res. Commun. 245:1998;90-93.
41. Kask A., Mutulis F., Muceniece R., Pähkla R., Mutule I., Wikberg J.E.S., Rägo L., Schiöth H.B. Discovery of a novel superpotent and selective melanocortin 4 receptor antagonist (HS024): evaluation in vitro and in vivo. Endocrinology. 139:1998;5006-5014.
42. Kask A., Rägo L., Korrovits P., Wikberg J.E.S., Schiöth H.B. Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y. Biochem. Biophys. Res. Commun. 248:1998;245-249.
43. Kask A., Rägo L., Wikberg J.E.S., Schiöth H.B. Evidence for involvement of the melanocortin 4 receptor in the effects of leptin on food intake. Eur. J. Pharmacol. 360:1998;15-19.
44. Kask A., Pähkla R., Irs A., Rägo L., Wikberg J.E.S., Schiöth H.B. Long-term administration of melanocortin 4 receptor sensitive antagonist (HS014) causes severe obesity and hyperphagia in rats. Neuroreport. 10:1999;707-711.
45. Kaye W.H. Anorexia nervosa, obsessional behaviour, and serotonin. Psychopharmacol. Bull. 33:1997;335-344.
46. Kesterson R.A., Huszar D., Lynch C.A., Simerly R.B., Cone R.D. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol. Endocrinol. 11:1997;630-637.
47. 4 receptor mRNA: predominance of MC4 in fetal rat nervous system. J. Neuroendocrinol. 10:1998;133-146.
48. Klungland H., Våge D.I., Gomez-Raya L., Adalsteinsson S., Lien S. The role of melanocyte-stimulating hormone (MSH) receptor in bovine coat color determination. Mammalian Genome. 6:1995;636-639.
49. Koppula S.-V., Robbins L.-S., Lu D., Baack E., White C.R. Jr., Swanson N.A., Cone R.D. Identification of common polymorphisms in the coding sequence of the human MSH receptor (MCIR) with possible biological effects. Hum. Mutat. 9:1997;30-36.
50. Krude H., Biebermann H., Luck W., Horn R., Brabant G., Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19:1998;155-157.
51. Kucera G.T., Bortner D.M., Rosenberg M.P. Overexpression of an Agouti cDNA in the skin of transgenic mice recapitulates dominant coat color phenotypes of spontaneous mutants. Dev. Biol. 173:1996;162-173.
52. Labbé O., Desarnaud F., Eggerickx D., Vassart G., Parmentier M. Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry. 33:1994;4543-4549.
53. Lindblom J., Schiöth H.B., Larsson A., Wikberg J.E.S., Bergström L. Autoradiographic discrimination of melanocortin receptors indicates that the MC3 subtype dominates in the medial brain. Brain Res. 810:1998;161-171.
54. Lipton J.M., Catania A., Delgado R. Peptide modulation of inflammatory processes within the brain. Neuroimmunomodulation. 5:1998;178-183.
55. Lu D., Willard D., Patel I.R., Kadwell S., Overton L., Kost T., Luther M., Chen W., Woychik R.P., Wikinson W.O., Cone R.D. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptors. Nature. 371:1994;799-802.
56. Luger T.A., Scholzen T., Grabbe S. The role of alpha-melanocyte-stimulating hormone in cutaneous biology. J. Invest. Dermatol. Symp. Proc. 2:1997;87-93.
57. Lyson K., Ceriani G., Takashima A., Catania A., Lipton J.M. Binding of anti-inflammatory alpha-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells. Neuroimmunomodulation. 1:1994;121-126.
58. Manna S.K., Aggarwal B.B. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-κB activation induced by various inflammatory agents. J. Immunol. 161:1998;2873-2880.
59. Mantzoros C., Flier J.S. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. J. Clin. Endocrinol. Metab. 82:1997;1845-1851.
60. Marrero M.B., Schieffer B., Paxton W.G., Heerdt L., Berk B.C., Delafontaine P., Bernstein K.E. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature. 375:1995;247-250.
61. Marklund L., Johansson Moller M., Sandberg K., Andersson L. A missense mutation in the gene for melanocyte-stimulating hormone receptor (MC1R) is associated with the chestnut coat color in horse. Mammalian Genome. 7:1996;895-899.
62. Morandini R., Boeynaems J.M., Hedley S.J., MacNeil S., Ghanem G. Modulation of ICAM-1 expression by alpha-MSH in human melanoma cells and melanocytes. J. Cell. Physiol. 175:1998;276-282.
63. Mountjoy K.G., Wild J.M. Melanocortin-4 receptor mRNA expression in the developing autonomic and central nervous systems. Brain Res. Dev. Brain Res. 107:1998;309-314.
64. Mountjoy K.G., Robbins L.S., Mortrud M.T., Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science. 257:1992;1248-1251.
65. Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8:1994;1298-1308.
66. Mucha R.F., van Ree J.M. Infusion of gamma 2-MSH produce a conditioned taste aversion in morphine-dependent rats. Psychopharmacology (Berl). 99:1989;140-142.
67. Mugridge K.G., Perretti M., Ghiara P., Parente L. Alpha-melanocyte-stimulating hormone reduces interleukin-1 beta effects on rat stomach preparations possibly through interference with a type I receptor. Eur. J. Pharmacol. 197:1991;151-155.
68. Oelofsen W., Ramachandran J. Studies of corticotropin receptors on rat adipocytes. Arch. Biochem. Biophys. 225:1983;414-421.
69. Perry W.L., Hustad C.M., Swing D.A., Jenkins N.A., Copeland N.G. A transgenic mouse assay for agouti protein activity. Genetics. 140:1995;267-274.
70. Poggioli R., Vergoni A.V., Bertolini A. ACTH-(1-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists. Peptides. 7:1986;843-848.
71. Prusis P., Frändberg P.-A., Muceniece R., Kalvinsh I., Wikberg J.E.S. A three dimensional model for the interaction of MSH with the melanocortin-1 receptor. Biochem. Biophys. Res. Commun. 210:1995;205-210.
72. Prusis P., Schiöth H.B., Muceniece R., Herzyk P., Afshar M., Hubbard R.E., Wikberg J.E.S. Modeling of the three-dimensional structure of the human melanocortin-1 receptor using an automated method and docking of a rigid cyclic MSH core peptide. J. Mol. Graphics Modelling. 15:1997;307-317.
73. Rajora N., Boccoli G., Catania A., Lipton J.M. Alpha-MSH modulates experimental inflammatory bowel disease. Peptides. 18:1997;381-385.
74. Rajora N., Boccoli G., Burns D., Sharma S., Catania A.P., Lipton J.M. alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation. J. Neurosci. 17:1997;2181-2196.
75. Robbins L.S., Nadeau J.H., Johnson K.R., Kelly M.A., Roselli-Rehfuss L., Baack E., Mountjoy K.G., Cone R.D. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell. 72:1993;827-834.
76. Roselli-Rehfuss L., Mountjoy K.G., Robbins L.S., Mortrud M.T., Low M.J., Tatro J.B., Entwistle M.L., Simerly R.B., Cone R.D. Identification of a receptor for γ melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. USA. 90:1993;8856-8860.
77. Schwartz M.W., Seeley R.J., Woods S.C., Weigle D.S., Campfield L.A., Burn P., Baskin D.G. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes. 46:1997;2119-2123.
78. Schiöth H.B., Muceniece R., Wikberg J.E.S. Characterization of the melanocortin 4 receptor by radioligand binding. Pharmacol. Toxicol. 79:1996;161-165.
79. Schiöth H.B., Chhajlani V., Muceniece R., Klusa V., Wikberg J.E.S. Major pharmacological distinction of the ACTH receptor from other melanocortin receptors. Life Sci. 59:1996;797-801.
80. Schiöth H.B., Muceniece R., Szardenings M., Prusis P., Wikberg J.E.S. Evidence indicating that the TM4, EL2 and TM5 of the melanocortin 3 receptor do not participate in ligand binding. Biochem. Biophys. Res. Commun. 229:1996;687-692.
81. Schiöth H.B., Muceniece R., Larsson M., Wikberg J.E.S. The melanocortin 1, 3, 4 or 5 receptors do not have a binding epitope for ACTH beyond the sequence of α-MSH. J. Endocrionol. 155:1997;73-78.
82. 6] substituted ACTH(4-10) analogues for the melanocortin receptors. Peptides. 18:1997;761-763.
83. 7] substituted MSH analogues for the melanocortin receptor subtypes. Peptides. 18:1997;1009-1013.
84. Schiöth H.B., Muceniece R., Wikberg J.E.S. Characterization of the binding of MSH-B, HP-228, GHRP-6 and 153N-6 to the human melanocortin receptor subtypes. Neuropeptides. 349:1997;359-366.
85. Schiöth H.B., Yook P., Muceniece R., Wikberg J.E.S., Szardenings M. Chimeric melanocortin 1/3 receptors; Identification of domains determining the specificity of MSH peptides. J. Biol. Chem. 272:1997;27943-27948.
86. Schiöth H.B., Muceniece R., Prusis P., Szardenings M., Lindeberg G., Sharma S.D., Hruby V.J., Wikberg J.E.S. Characterisation of D117A and, H260A mutations in the melanocortin 1 receptor. Mol. Cell. Endocrinol. 126:1997;213-219.
87. Schiöth H.B., Petersson S., Muceniece R., Szardenings M., Wikberg J.E.S. Deletions of the N-terminal regions of the human melanocortin receptors. FEBS Lett. 410:1997;223-228.
88. Schiöth H.B., Muceniece R., Larsson M., Mutulis F., Szardenings M., Prusis P., Lindeberg G., Wikberg J.E.S. Binding of cyclic and linear MSH core peptides to melanocortin receptor subtypes. Eur. J. Pharmacol. 319:1997;369-373.
89. Schiöth H.B., Mutulis F., Muceniece R., Prusis P., Wikberg J.E.S. Discovery of novel melanocortin 4 receptor selective MSH analogues. Br. J. Pharmacol. 124:1998;75-82.
90. Schiöth H.B., Fredriksson A., Carlsson C., Yook P., Muceniece R., Wikberg J.E.S. Evidence indicating that the extracellular loops of the mouse MC5 receptor do not participate in ligand binding. Mol. Cell. Endocrinol. 139:1998;109-115.
91. Seeley R.J., Yagaloff K.A., Disher S.L., Burn P., Thiele T.E., van Dijk G., Baskin D.G., Scwartz M.W. Melanocortin receptors in leptin effects. Nature. 390:1997;349.
92. Shutter J.R., Graham M., Kinsey A.C., Scully S., Luthy R., Stark K.L. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev. 11:1997;593-602.
93. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-κB. Annu. Rev. Cell. Biol. 10:1994;405-455.
94. Slominski A., Ermak G., Mihm M. ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J. Clin. Endocrinol. Metab. 81:1996;2746-2749.
95. Smith K.A., Fairburn C.G., Cowen P.J. Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. Arch. Gen. Psychiatry. 56:1999;171-176.
96. Stanley B.G., Kyrkouli S.E., Lampert S., Leibowitz S.F. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides. 7:1986;1189-1192.
97. Star R.A., Rajora N., Huang J., Stock R.C., Catania A., Lipton J.M. Evidence of autocrine modulation of macrophage nitric oxide synthase by α-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. USA. 92:1995;8016-8020.
98. Szardenings M., Törnroth S., Muceniece R., Keinänen K., Kuusinen A., Wikberg J.E.S. Phage display selection on whole cells yields a peptide specific for melanocortin receptor 1. J. Biol. Chem. 272:1997;27943-27948.
99. Takeuchi S., Takahashi S. Melanocortin receptor genes in the chicken-tissue distributions. Gen. Comp. Endocrinol. 112:1998;220-231.
100. Tatro J.B. Receptor biology of the melanocortins, a family of neuroimmunimodulatory peptides. Neuroimmunomodulation. 3:1996;259-284.
101. Thörnvall M., Dimitrou A., Xu X., Larsson E., Chhajlani V. Immunohistochemical detetion of the melanocortin 1 receptor in human testis, ovary and placenta using specific monoclonal antibody. Horm. Res. 48:1997;215-218.
102. Våge D.I., Lu D., Klungland H., Lien S., Adalsteinsson S., Cone R.D. A non-epistatic interaction of agouti and extension in the fox, Vuples vulpes. Nat. Genet. 311-315:1997;15.
103. Valverde P., Healy E., Jackson I., Rees J.L., Thody A.J. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat. Genet. 11:1995;328-330. see comments.
104. van de Ment H., Hamers F.P.T., Lankhorst A.J., Joosten E.A.J., Gispen W.H. Beneficial effects of the melanocortin α-melanocytestimulating hormone on clinical and neurophysiological recovery after exeperimental spinal cord injury. Neurosurgery. 40:1997;122-131.
105. van der Kraan M., Adan R.A., Entwistle M.L., Gispen W.H., Burbach J.P.H., Tatro J.B. Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. Endocrinology. 139:1998;2348-2355.
106. Vanetti M., Schönrock C., Meyerhof W., Höllt V. Molecular cloning of a bovine MSH receptor which is highly expressed in the testis. FEBS Lett. 348:1994;268-272.
107. Vergoni A.V., Poggioli R., Bertolini A. Corticotropin inhibits food intake in rats. Neuropeptides. 7:1986;153-158.
108. Vergoni A.V., Bertolini A., Wikberg J.E.S., Schiöth H.B. Selective melanocortin MC4 receptor blockade reduces immobilization stress-induced anorexia. Eur. J. Pharmacol. 369:1999;11-15.
109. Versteeg D.H., Van Bergen P., Adan R.A., De Wildt D.J. Melanocortins and cardiovascular regulation. Eur. J. Pharmacol. 360:1998;1-14.
110. Wakamatsu K., Graham A., Cook D., Thody A.J. Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Res. 10:1997;288-297.
111. White J.E., Engel F.L. Lipolytic action of cotricotropin on rat adipose tissue in vitro. J. Clin. Invest. 37:1958;1556-1563.
112. Wilson B.D., Ollmann M.M., Kang L., Stoffel M., Bell Gl., Barsh G.S. Structure and function of ASP, the human homolog of the mouse agouti gene. Hum. Mol. Genet. 4:1995;223-230.
113. Wong K.Y., Rajora N., Boccoli G., Lipton J.M. A potential mechanism of local anti-inflammatory action of alpha-melanocyte stimulating hormone within the brain: modulation of tumour necrosis factor-alpha production by human astrocytic cells. Neuroimmunomodulation. 4:1997;37-41.
114. Xia Y., Wikberg J.E.S. In situ hybridization histochemical localization of ACTH receptor mRNA in mouse adrenal gland. Cell Tissue Res. 286:1996;63-68.
115. Xia Y., Wikberg J.E.S. Postnatal expression of melanocortin-3 receptor mRNA in rat ventral tegmental area. Neuropharmacol. 36:1997;217-224.
116. Xia Y., Skoog V., Muceniece R., Chhajlani V., Wikberg J.E.S. Polyclonal antibodies against human melanocortin MC1 receptor: preliminary immunohistochemical localisation of melanocortin MC1 receptor to malignant melanoma cells. Eur. J. Pharmacol. 288:1995;277-283.
117. Xia Y., Wikberg J.E.S., Chhajlani V. Expression of melanocortin 1 receptor in periaqueductal gray matter. Mol. Neurosci. 6:1995;2193-2196.
118. Xia Y., Muceniece R., Wikberg J.E.S. Immunological localisation of melanocortin 1 receptor on the cell surface of WM266-4 human melanoma cells. Cancer Lett. 98:1995;157-162.